SCHEMBL13115698

SCHEMBL13115698

CN(CCNC(=O)Cn1ncc2c1CCCC2)C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40
GABRG3 Q99928 1/20 0.40
GABRQ Q9UN88 1/20 0.40
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.39
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193832 0.80 MAPT (0.45) BCHEACHEMAPTTP53ALDH1A1
SCHEMBL3602593 0.78 TSHR (0.57) BCHEACHEMAPTTP53RECQL
SCHEMBL3188347 0.75 MAPT (0.58) MAPTTP53ALDH1A1LMNAGAA
SCHEMBL3607948 0.75 KMT2A (0.39) BCHEACHEMAPTTP53ALDH1A1
SCHEMBL3603709 0.75 KMO (0.43) BCHEACHEMAPTTP53ALDH1A1
SCHEMBL3585647 0.74 ATM (0.43) MAPTTP53ALDH1A1HTTLMNA
SCHEMBL3597424 0.73 TSHR (0.41) BCHEACHEMAPTTP53RAB9A
SCHEMBL3195471 0.73 POLB (0.60) MAPTTP53ALDH1A1LMNAGAA
SCHEMBL3185890 0.73 POLB (0.60) MAPTTP53ALDH1A1LMNAGAA
SCHEMBL3185549 0.73 POLB (0.50) MAPTTP53ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 GABRP 1320/4885GABRD 3769/4885GABRA1 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.